News and events
Life sciences
Our articles in Life sciences are shown below.
-
UCL and Cambridge share in £50m of new funding to help stimulate UK economy
University College London (UCL) and Cambridge have been awarded a share of a government investment of £50m into UK’s leading universities to drive growth, the Minister for Universities and Science has announced.
-
The artificial pancreas that keeps tabs on sugar
Development of a sophisticated artificial pancreas holds potential to transform the lives of patients with Type 1 diabetes.
-
Horizon Discovery announces collaboration with AstraZeneca
Cambridge Enterprise portfolio company Horizon Discovery and AstraZeneca have entered into an exclusive collaboration and licence agreement to explore Horizon’s first-in-class kinase target programme, HD-001, as a means of developing novel therapies for multiple cancer types.
-
Horizon Discovery establishes two new Centres of Excellence in Cambridge
Leading researchers Steve Jackson and David Rubinsztein to apply rAAV gene editing technology in studies of oncology and neurodegenerative disease.
-
Horizon Discovery wins most promising company at World Conference on Personalised Medicine
Award based on technology, performance to date, and forward plans
-
Food industry giants call for pitches from University inventors
University inventors and entrepreneurs whose research has applications in the food and consumer goods sectors will have the opportunity to demonstrate their ideas to representatives from major multinational companies, at an event to be held at the Institute for Manufacturing this spring.
-
Fast-tracking dementia diagnosis
The amount of time it takes to diagnose dementia could be reduced from the current 18 months to just three months, thanks in part to technology originally developed at the University of Cambridge.
-
Cambridge software improves quality of sound for hearing aid users
A new software product developed by researchers at the University of Cambridge could greatly improve sound perception for users of hearing aids.
-
New MS drug proves effective where others have failed
Alemtuzumab, a drug previously used to treat a type of leukaemia, shown to help people with early multiple sclerosis who relapsed on previous drugs as well as patients who had not yet been treated.
-
The role of stem cells in developing new drugs
Cambridge team which developed method to generate liver cells from skin cells has formed a new company to supply stem cell products to the drug discovery and regenerative medicine sectors.